Phase1,Randomized,Open-Label,Parallel-Group,Relative Bioavailability Study to Investigate PK,Including Food Effect,Safety and Tolerability of Single Doses of New Immediate Release Tablet Formulations of Emodepside (BAY 44-4400),Compared to Oral Solution,in Healthy Male Subjects

Name: Phase1,Randomized,Open-Label,Parallel-Group,Relative Bioavailability Study to Investigate PK,Including Food Effect,Safety and Tolerability of Single Doses of New Immediate Release Tablet Formulations of Emodepside (BAY 44-4400),Compared to Oral Solution,in Healthy Male Subjects
Creator: Vivli
Published: 2025-11-17 20:51:53
License: 暂无描述

DataCite Commons2025-11-17 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00011757/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

This study evaluates 2 new immediate release (IR)-tablet formulations of emodepside and they will be compared to the oral liquid service formulation (LSF) used in the FIH Single Ascending Dose study (DNDi-EMO-001 study) (CT.gov identifier: NCT02661178)

提供机构：

Vivli

创建时间：

2025-09-10